Home/Liberate Bio/Michael Mitchell, PhD

MM

Michael Mitchell, PhD

Co-Founder (University of Pennsylvania)

Therapeutic Areas

Oncology Autoimmunity

Liberate Bio Pipeline

Drug	Indication	Phase
In Vivo CAR-M Program	B-cell driven autoimmune diseases / Hematologic cancers	Preclinical

Leadership Team at Liberate Bio

Shawn Davis, PhD

Walter Strapps, PhD

Nessan Bermingham, PhD

Co-Founder (Khosla Ventures)

Theresa M. Reineke, PhD

Co-Founder (University of Minnesota)

View full Liberate Bio profile